Cite

HARVARD Citation

    Gelsomino, F. et al. (2020). Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial). Therapeutic advances in medical oncology. p. . [Online]. 
  
Back to record